BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29739029)

  • 1. [Systemic Corticosteroids in Non-infectious Uveitis].
    Neß T
    Klin Monbl Augenheilkd; 2018 May; 235(5):592-596. PubMed ID: 29739029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Infectious Uveitis: Optimising the Therapeutic Response.
    Airody A; Heath G; Lightman S; Gale R
    Drugs; 2016 Jan; 76(1):27-39. PubMed ID: 26645222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune uveitis.
    Whitcup SM; Nussenblatt RB
    Ann N Y Acad Sci; 1993 Nov; 696():307-18. PubMed ID: 8109836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of chronic non infectious uveitis].
    Le Thi Huong D; Cassoux N; Lebrun-Vignes B; Wechsler B; Bodaghi B; Lehoang P; Piette JC
    Rev Med Interne; 2007 Apr; 28(4):232-41. PubMed ID: 17275966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC; Ribi C; Guex-Crosier Y
    Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for the treatment of noninfectious uveitis.
    Pleyer U; Pohlmann D; Kardeş E; Poddubnyy D; Rademacher J
    Expert Opin Emerg Drugs; 2019 Sep; 24(3):173-190. PubMed ID: 31498689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autoimmune hepatitis in a patient with uveitis].
    Maíz B; Odriozola M; Blanco A; Fernández J; Castiella A
    Gastroenterol Hepatol; 2005 Dec; 28(10):656-7. PubMed ID: 16373020
    [No Abstract]   [Full Text] [Related]  

  • 8. Current therapeutic approaches to autoimmune chronic uveitis in children.
    Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
    Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.
    Gallego-Pinazo R; Dolz-Marco R; Martínez-Castillo S; Arévalo JF; Díaz-Llopis M
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):38-45. PubMed ID: 23441991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
    Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
    Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of uveitis - current trends.
    Babu K; Mahendradas P
    Indian J Ophthalmol; 2013 Jun; 61(6):277-83. PubMed ID: 23803479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.
    Peretz A; Guillaume MP; Casper-Velu L
    Acta Clin Belg; 2002; 57(3):142-7. PubMed ID: 12212355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveitis for the non-ophthalmologist.
    Burkholder BM; Jabs DA
    BMJ; 2021 Feb; 372():m4979. PubMed ID: 33536186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the treatment of uveitis: an update.
    Lyon F; Gale RP; Lightman S
    Expert Opin Investig Drugs; 2009 May; 18(5):609-16. PubMed ID: 19388878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis.
    Dunn JP
    Prim Care; 2015 Sep; 42(3):305-23. PubMed ID: 26319340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting-edge issues in autoimmune uveitis.
    Levy RA; de Andrade FA; Foeldvari I
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):214-23. PubMed ID: 21913066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
    Pleyer U; Pohlmann D; Stübiger N
    Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.
    Prete M; Dammacco R; Fatone MC; Racanelli V
    Clin Exp Med; 2016 May; 16(2):125-36. PubMed ID: 25820692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol.
    Blair J; Barry R; Murray PI; Moore DJ; Denniston AK
    Syst Rev; 2018 Jun; 7(1):83. PubMed ID: 29885659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.